Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew L. Turner currently holds 593 shares of WATSON PHARMACEUTICALS INC (WPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew L. Turner has been a net seller of WPI stock. They have purchased $111.3K and sold $4.7M worth of shares.
Andrew L. Turner's most recent insider trade was on Mar 17, 2015, when they sold 549 shares at $307.51 per share.
Andrew L. Turner serves as Executive at WATSON PHARMACEUTICALS INC (WPI). They have executed 57 insider transactions totaling $4.8M over their tenure at the company.
Andrew L. Turner holds the position of Executive at WATSON PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Andrew L. Turner has shown a selling trading pattern, with $111.3K in total purchases and $4.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew L. Turner was on May 29, 2012, when they sold $1.5M worth of WPI shares. This transaction involved 20,000 shares at $73.59 per share.
Andrew L. Turner currently owns 593 shares of WATSON PHARMACEUTICALS INC (WPI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew L. Turner's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew L. Turner has 57 Form 4 filings on record as an insider at WATSON PHARMACEUTICALS INC.
Set alerts for Andrew L. Turner and 40,000+ other insiders.